The role of endocannabinoids in Alzheimer's disease

QR Code

The role of endocannabinoids in Alzheimer's disease

The endocannabinoid system (ECS) comprises the endocannabinoids (ECs), including anandamide (AEA) and 2-arachidonoyl glycerol (2AG), which interact with the G protein-coupled type-1 and type-2 cannabinoid receptors(CB1 and CB2 respectively). The ECS is thought to have a role in a number of central p...

Full description

Bibliographic Details
Main Author:	Maroof, Nazia
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2013
Online Access:	https://eprints.nottingham.ac.uk/30577/

Similar Items

Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer’s disease: a systematic review and meta-analysis of animal studies
by: Kamaruzzaman, Mohd Amir, et al.
Published: (2023)

An investigation into the role and effects of the endocannabinoid system in adipocytes
by: Cable, Jemma
Published: (2012)

Endocannabinoid turnover and function
by: Patel, Annie
Published: (2010)

Endocannabinoid modulation of nociceptive processing
by: Norris, Leonie
Published: (2010)

Molecular characterization of endocannabinoid signalling
by: Abdulmaqsood, Yousra
Published: (2021)

The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)

Endocannabinoid hydrolases in human blood fractions
by: Anajirih, Nuha
Published: (2019)

Molecular and functional characterization of endocannabinoid hydrolases
by: Mahmood, Nada
Published: (2018)

Endocannabinoid Regulation of Learned Fear Inhibition
by: Warren, William George
Published: (2023)

The effects of endocannabinoids and phytocannabinoids on bronchial epithelial permeability
by: Shang, Valerie C.M.
Published: (2016)

The role of gonadotoprins in Alzheimer’s disease: potential neurodegenerative mechanisms
by: Barron, A., et al.
Published: (2006)

Diet and Alzheimer's disease
by: Creegan, R., et al.
Published: (2013)

Alzheimer's disease talk
by: The Star,
Published: (2012)

Models of Alzheimer’s Disease
by: Chen, M., et al.
Published: (2014)

Endocannabinoid metabolism and peroxisome proliferator-activated receptor signalling
by: Dionisi, Mauro
Published: (2010)

Investigating the role of CLU PICALM and CR1 in Alzheimer's disease
by: Lord, Jenny
Published: (2014)

Possible epigenetic role of vitexin in regulating neuroinflammation in Alzheimer’s disease
by: Yahaya, Muhamad Afiq Faisal, et al.
Published: (2020)

Rationalising the role of Keratin 9 as a biomarker for Alzheimer’s disease
by: Richens, Joanna L., et al.
Published: (2016)

Endocannabinoids modulate human blood-brain barrier permeabilityin vitro
by: Hind, William H., et al.
Published: (2015)

Animal Models of Alzheimer's Disease
by: Newman, M., et al.
Published: (2017)

Molecular Genetics of Alzheimer's Disease
by: Verdile, Giuseppe, et al.
Published: (2009)

Consumption of fish and Alzheimer's Disease
by: Newton, Wendy, et al.
Published: (2011)

The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
by: Stanley, Christopher P., et al.
Published: (2016)

Investigating genetic variation in Alzheimer’s disease
by: Patel, Tulsi
Published: (2018)

The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action
by: Fernando, W., et al.
Published: (2015)

A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition
by: Zachariou, Margarita, et al.
Published: (2013)

An investigation of pain mechanisms in a model of osteoarthritis : modulation by the endocannabinoid receptor system
by: Staniaszek, Lydia Ewa
Published: (2010)

Age dependent plasticity in endocannabinoid modulation of pain processing through postnatal development
by: H-T. Kwok, Charlie, et al.
Published: (2017)

Changes in Brain Transcripts Related to Alzheimer’s Disease in a Model of HFE Hemochromatosis are not Consistent with Increased Alzheimer’s Disease Risk
by: Johnstone, D., et al.
Published: (2012)

Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
by: Bharadwaj, P., et al.
Published: (2013)

Genetic underpinnings in Alzheimer’s disease – A review
by: Moustafa, Ahmed A., et al.
Published: (2017)

Investigation into patterns of epigenetic regulation of Alzheimer’s disease
by: Boden, Kirsty
Published: (2019)

Memory, ageing and Alzheimer's disease: the case for Malaysia
by: Dzulkifli, Mariam Adawiah
Published: (2012)

Investigating polygenic risk scores in Alzheimer's disease
by: Chaudhury, Sultan Raja
Published: (2024)

Anatomical analysis of brain MRI in Alzheimer’s disease
by: Farzan, Ali, et al.
Published: (2014)

Alzheimer's disease: undiagnosed due to lack of awareness
by: Roslan, Muhammad Basir
Published: (2020)

Screening techniques for drug discovery in Alzheimer's disease
by: Maniam, Sandra, et al.
Published: (2024)

The genetics of Alzheimer's disease: putting flesh on the bones
by: Medway, C., et al.
Published: (2014)

Postural Stability in Older Adults With Alzheimer Disease
by: Mesbah, N., et al.
Published: (2017)

Chylomicron amyloi-beta in the aetiology of Alzheimer's disease
by: Takechi, Ryu, et al.
Published: (2008)